ES2176792T3 - Tabletas que contienen una resina de intercambio ionico. - Google Patents
Tabletas que contienen una resina de intercambio ionico.Info
- Publication number
- ES2176792T3 ES2176792T3 ES97944125T ES97944125T ES2176792T3 ES 2176792 T3 ES2176792 T3 ES 2176792T3 ES 97944125 T ES97944125 T ES 97944125T ES 97944125 T ES97944125 T ES 97944125T ES 2176792 T3 ES2176792 T3 ES 2176792T3
- Authority
- ES
- Spain
- Prior art keywords
- tablets
- coated
- exchange resin
- ion exchange
- tablets containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 title 1
- 239000003456 ion exchange resin Substances 0.000 title 1
- 229920003303 ion-exchange polymer Polymers 0.000 title 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003957 anion exchange resin Substances 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000006116 polymerization reaction Methods 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE DESCRIBEN COMPRIMIDOS HIPOCOLESTEROLEMIANTES RECUBIERTOS O NO RECUBIERTOS PARA LA ADMINISTRACION ORAL, QUE INCLUYEN UNA RESINA DE INTERCAMBIO ANIONICO DE FORMULA (I), EN LA CUAL X REPRESENTA UN CONTRAION FISIOLOGICAMENTE ACEPTABLE; Y P REPRESENTA UN GRADO MEDIO DE POLIMERIZACION, Y ES MAYOR QUE 10.000, DIOXIDO DE SILICIO Y CELULOSA CRISTALINA, PERO QUE NO CONTIENEN AGUA. LOS COMPRIMIDOS NO RECUBIERTOS SE RECUBREN PREFERIBLEMENTE CON SUSTANCIAS CELULOSICAS. LOS COMPRIMIDOS SON FACILES DE TOMAR, PUESTO QUE NO SON AMARGOS. LA DOSIS DE LOS COMPRIMIDOS PUEDE DISMINUIRSE, PUESTO QUE LOS COMPRIMIDOS PUEDEN CONTENER UNA GRAN CANTIDAD DE PRINCIPIO ACTIVO. LA MEZCLA QUE INCLUYE LOS COMPONENTES CONSTITUYENTES PUEDE FORMARSE DIRECTAMENTE EN COMPRIMIDOS EN AUSENCIA DE AGUA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP29332896A JP4010585B2 (ja) | 1996-10-15 | 1996-10-15 | 陰イオン交換樹脂を含有する錠剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2176792T3 true ES2176792T3 (es) | 2002-12-01 |
Family
ID=17793408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97944125T Expired - Lifetime ES2176792T3 (es) | 1996-10-15 | 1997-10-15 | Tabletas que contienen una resina de intercambio ionico. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6197290B1 (es) |
| EP (1) | EP0873129B1 (es) |
| JP (1) | JP4010585B2 (es) |
| KR (1) | KR19990072020A (es) |
| CN (1) | CN1111413C (es) |
| AT (1) | ATE216248T1 (es) |
| CA (1) | CA2240402A1 (es) |
| DE (1) | DE69712033T2 (es) |
| DK (1) | DK0873129T3 (es) |
| ES (1) | ES2176792T3 (es) |
| ID (1) | ID21038A (es) |
| PT (1) | PT873129E (es) |
| RU (1) | RU2180219C2 (es) |
| TW (1) | TW528605B (es) |
| UA (1) | UA51686C2 (es) |
| WO (1) | WO1998016237A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000008063A1 (fr) * | 1998-08-05 | 2000-02-17 | Hisamitsu Pharmaceutical Co., Inc. | Procede de production d'un polymere cationique |
| US6413394B1 (en) * | 1999-07-08 | 2002-07-02 | Thomas Y. Shen | Disposable plate electrode with biological active film |
| JP3883505B2 (ja) | 2000-09-06 | 2007-02-21 | 三菱ウェルファーマ株式会社 | 経口粒製剤 |
| WO2002043761A1 (en) * | 2000-11-28 | 2002-06-06 | Mitsubishi Pharma Corporation | Antiobestic agents and health foods |
| CN1953756A (zh) | 2004-03-26 | 2007-04-25 | 三菱制药株式会社 | 胰岛素抗性改善剂 |
| US20060177415A1 (en) * | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
| ES2398477T3 (es) | 2006-06-16 | 2013-03-19 | Mitsubishi Tanabe Pharma Corporation | Agente para la prevención y/o el tratamiento de glomerulopatía |
| EP2050456A4 (en) * | 2006-08-09 | 2013-01-23 | Mitsubishi Tanabe Pharma Corp | COMPRESSED |
| RU2668499C2 (ru) * | 2015-03-12 | 2018-10-01 | Закрытое Акционерное Общество "Фармфирма "Сотекс" | Фармацевтическая композиция в форме таблеток, покрытых кишечнорастворимой оболочкой, и способ ее получения |
| CN107233933A (zh) * | 2017-05-09 | 2017-10-10 | 安徽皖东化工有限公司 | 一种水体净化用苯乙烯阴离子交换树脂的制备方法 |
| CN116887866A (zh) | 2020-12-03 | 2023-10-13 | 巴特尔纪念研究院 | 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法 |
| WO2022216977A1 (en) | 2021-04-07 | 2022-10-13 | Batelle Memorial Institute | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| WO2025072751A1 (en) | 2023-09-29 | 2025-04-03 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| US12441996B2 (en) | 2023-12-08 | 2025-10-14 | Battelle Memorial Institute | Use of DNA origami nanostructures for molecular information based data storage systems |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI67483C (fi) * | 1977-02-17 | 1985-04-10 | Merck & Co Inc | Foerfarande foer framstaellning av ett icke adhesivt friflytande farmakologiskt godtagbart gallsyrakomplexbildande adsorbatpreparat |
| SE445013B (sv) * | 1979-06-21 | 1986-05-26 | Landstingens Inkopscentral | Medel for att forebygga eller behandla infektioner hos menniskor och djur |
| ZA87279B (en) * | 1986-01-17 | 1987-09-30 | Chugai Pharmaceutical Co Ltd | Method for production of stable nicorandil preparation |
| US4836756A (en) * | 1986-08-28 | 1989-06-06 | Nippon Pillar Packing Co., Ltd. | Pneumatic pumping device |
| US4820522A (en) * | 1987-07-27 | 1989-04-11 | Mcneilab, Inc. | Oral sustained release acetaminophen formulation and process |
| JPH01172324A (ja) | 1987-12-15 | 1989-07-07 | Armour Internatl Co | コレスチラミン組成物及びその製造法 |
| KR890014100A (ko) * | 1988-03-24 | 1989-10-21 | 우에하라 아끼라 | 콜레스테롤 강하제 |
| US5178854A (en) | 1988-03-24 | 1993-01-12 | Taisho Pharmaceutical Co., Ltd. | Cholesterol-lowering agents |
| US4956182A (en) * | 1989-03-16 | 1990-09-11 | Bristol-Myers Company | Direct compression cholestyramine tablet and solvent-free coating therefor |
| JPH02286621A (ja) * | 1989-04-26 | 1990-11-26 | Mitsubishi Kasei Corp | 経口コレステロール低下剤 |
| DE4121127A1 (de) * | 1991-06-26 | 1993-01-14 | Rettenmaier & Soehne Gmbh & Co | Hilfsstoff zur trockenen direkttablettierung und verfahren zur herstellung desselben |
| DE69328741T2 (de) * | 1992-01-14 | 2000-09-07 | Hisamitsu Pharmaceutical Co., Inc. | Unvernetztes Anion-Austauscherharz und diesen enthaltende pharmazeutische Zusammensetzung |
| RU2036642C1 (ru) * | 1992-05-29 | 1995-06-09 | Малое предприятие "Фармапэк" | Способ получения бронхолитической лекарственной композиции пролонгированного действия на основе теофиллина |
| JP3552285B2 (ja) | 1993-08-03 | 2004-08-11 | 三菱化学株式会社 | 経口コレステロール低下剤 |
| RU2093525C1 (ru) * | 1993-12-14 | 1997-10-20 | Институт органической химии Уфимского научного центра РАН | Сшитый поливиниловый спирт с иммобилизованной м-аминофенилбороновой кислотой в качестве сорбента для аффинного определения гликозилированного гемоглобина |
| TW438608B (en) * | 1995-08-02 | 2001-06-07 | Hisamitsu Pharmaceutical Co | A tablet containing anion exchange resin |
-
1996
- 1996-10-15 JP JP29332896A patent/JP4010585B2/ja not_active Expired - Fee Related
-
1997
- 1997-10-15 ES ES97944125T patent/ES2176792T3/es not_active Expired - Lifetime
- 1997-10-15 RU RU98113319/14A patent/RU2180219C2/ru active
- 1997-10-15 UA UA98073742A patent/UA51686C2/uk unknown
- 1997-10-15 TW TW086115101A patent/TW528605B/zh not_active IP Right Cessation
- 1997-10-15 WO PCT/JP1997/003720 patent/WO1998016237A1/en not_active Ceased
- 1997-10-15 DK DK97944125T patent/DK0873129T3/da active
- 1997-10-15 KR KR1019980704313A patent/KR19990072020A/ko not_active Ceased
- 1997-10-15 US US09/091,069 patent/US6197290B1/en not_active Expired - Fee Related
- 1997-10-15 EP EP97944125A patent/EP0873129B1/en not_active Expired - Lifetime
- 1997-10-15 PT PT97944125T patent/PT873129E/pt unknown
- 1997-10-15 CN CN97191436A patent/CN1111413C/zh not_active Expired - Fee Related
- 1997-10-15 CA CA002240402A patent/CA2240402A1/en not_active Abandoned
- 1997-10-15 DE DE69712033T patent/DE69712033T2/de not_active Expired - Fee Related
- 1997-10-15 ID IDW980023A patent/ID21038A/id unknown
- 1997-10-15 AT AT97944125T patent/ATE216248T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69712033D1 (de) | 2002-05-23 |
| EP0873129A1 (en) | 1998-10-28 |
| KR19990072020A (ko) | 1999-09-27 |
| PT873129E (pt) | 2002-09-30 |
| US6197290B1 (en) | 2001-03-06 |
| JP4010585B2 (ja) | 2007-11-21 |
| TW528605B (en) | 2003-04-21 |
| AU4572697A (en) | 1998-05-11 |
| DK0873129T3 (da) | 2002-07-01 |
| UA51686C2 (uk) | 2002-12-16 |
| JPH10114661A (ja) | 1998-05-06 |
| RU2180219C2 (ru) | 2002-03-10 |
| ATE216248T1 (de) | 2002-05-15 |
| DE69712033T2 (de) | 2002-08-22 |
| CN1111413C (zh) | 2003-06-18 |
| AU723340B2 (en) | 2000-08-24 |
| EP0873129B1 (en) | 2002-04-17 |
| WO1998016237A1 (en) | 1998-04-23 |
| CA2240402A1 (en) | 1998-04-23 |
| CN1204965A (zh) | 1999-01-13 |
| ID21038A (id) | 1999-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2176792T3 (es) | Tabletas que contienen una resina de intercambio ionico. | |
| BG100933A (en) | Polymer coated tablets comprising amoxycilin and clavulanate | |
| IS4329A (is) | Fjöleiningaskammtar í töfluformi sem innihalda prótónupumpublokkara | |
| CA2274074A1 (en) | Novel compounds with analgesic effect | |
| GEP20033131B (en) | Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity | |
| WO1996017587A3 (en) | Oral compositions containing stabilized stannous compounds | |
| CA2239174A1 (en) | Novel compounds with analgesic effect | |
| MY132705A (en) | Novel compounds with analgesic effect | |
| BG101781A (bg) | Твърд препарат, съдържащ активно вещество | |
| CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
| IS1694B (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
| DE69701532D1 (de) | Orale zusammensetzung gegen zahnbelag | |
| MY104010A (en) | Pharmaceutical compositions. | |
| AU5683796A (en) | Novel pharmaceutical pellet formulation | |
| EP0375628A3 (en) | Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment | |
| PL332724A1 (en) | Local anaesthetic for extracorporeal use | |
| FI962056A0 (fi) | Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan | |
| EE9600202A (et) | Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm | |
| TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
| RU95121837A (ru) | Фармацевтическая композиция, обладающая иммуномоделирующим и гиполипидемическим действием | |
| GR1002731B (el) | Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες. | |
| TR200102087T2 (tr) | Yeni morfolinbenzamid tuzları | |
| DE69722594D1 (de) | Pulverförmiges arzneimittel enthaltend interzelluläres adhäsionsmolekül | |
| PL350413A1 (en) | Pharmaceutical effervescent formulation containing metamizol | |
| NZ505080A (en) | Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid |